- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Warburtons chomps on Artful Baker
Break maker's Batch Ventures will announce our second investment later this month.
Feb 14, 2021Kraken Ventures awakes for crypto
Brandon Gath, previously head of corporate development at Kraken, has been made general partner of Kraken Ventures.
Feb 14, 2021SR One expands venture team
Chris Chai and Peter Van Vlasselaer, both former executives at SR One portfolio companies, have been hired by the GSK-backed VC firm as venture partners.
Feb 12, 2021Corporate venturing deal net: 8-12 February 2021
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Feb 12, 2021Alphabet helps provide $15m for Nothing
The stealthy consumer device startup took its total funding to $22m in just four months, with Alphabet unit GV leading its series A round.
Feb 12, 2021Rover fetches SPAC for reverse merger
The Petco-backed pet services provider is set to be valued at about $1.6bn in a deal that will involve it listing on the Nasdaq Capital Market.
Feb 12, 2021Nationwide expands venture capital allocation to $350m
The financial services and insurance group had initially earmarked about $100m for strategic investments in 2017 and has since backed 25 companies.
Feb 12, 2021Hyperfine finds $90m in series D round
Alphabet's GV unit and Huami both took part as the portable MRI device developer completed an oversubscribed series D round.
Feb 12, 2021GrubMarket gets $90m in series D
Marubeni Ventures helped the online fresh food supplier push its overall funding past the $240m mark as it looks to expand further across the United States.
Feb 12, 2021Funds and incubators: February 8-12, 2021
A round up of the week's new fund and incbuator launches.
Feb 12, 2021Binhui Biotech brings in series C funding
The Lepu-backed genetic cancer therapy developer has completed a $94.9m round co-led by CICC Capital, Share Capital, Vertex Ventures China and Qianhai FOF.
Feb 12, 2021Pipeline Therapeutics sucks up $80m
Cleva Pharma Capital backed a series C round that will support the clinical progress of drug candidates for sensorineural hearing loss and multiple sclerosis.
Feb 12, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


